Considerations on package inserts for chimeric antigen receptor T cells indicated for hematological malignancy
A number of chimeric antigen receptor T cells have been marketed in China,which bring new therapeutic options for patients with hematologic tumors.Compared with other drugs,the clinical application of such living cell products has certain special features.Package insert is the carrier of basic information,safety and effectiveness data of drugs,and is an important basis of rationally use for medical personnel and patients.In this paper,we mainly discuss the requirements for writing package inserts of chimeric antigen receptor T cells with cases,in order to provide reference for package inserts and improve the understanding in clinical application.
chimeric antigen receptor T cellpackage insertclinical application
国家科技期刊平台
NSTL
万方数据
维普
